ProShare Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,011
| Closed | -$13.2K | – | 2097 |
|
|
2024
Q2 | $13.2K | Sell |
1,011
-346
| -25% | -$4.5K | ﹤0.01% | 1826 |
|
|
2024
Q1 | $30.7K | Buy |
1,357
+107
| +9% | +$2.42K | ﹤0.01% | 1955 |
|
|
2023
Q4 | $16.2K | Sell |
1,250
-229
| -15% | -$2.97K | ﹤0.01% | 1928 |
|
|
2023
Q3 | $29.7K | Buy |
1,479
+5
| +0.3% | +$101 | ﹤0.01% | 1762 |
|
|
2023
Q2 | $39.6K | Buy |
1,474
+339
| +30% | +$9.1K | ﹤0.01% | 1791 |
|
|
2023
Q1 | $66.2K | Buy |
1,135
+20
| +2% | +$1.17K | ﹤0.01% | 1645 |
|
|
2022
Q4 | $56.9K | Buy |
1,115
+108
| +11% | +$5.51K | ﹤0.01% | 1725 |
|
|
2022
Q3 | $83K | Buy |
1,007
+24
| +2% | +$1.98K | ﹤0.01% | 1595 |
|
|
2022
Q2 | $66K | Sell |
983
-437
| -31% | -$29.3K | ﹤0.01% | 1666 |
|
|
2022
Q1 | $158K | Sell |
1,420
-338
| -19% | -$37.6K | ﹤0.01% | 1943 |
|
|
2021
Q4 | $170K | Buy |
1,758
+68
| +4% | +$6.58K | ﹤0.01% | 2086 |
|
|
2021
Q3 | $148K | Sell |
1,690
-455
| -21% | -$39.8K | ﹤0.01% | 1849 |
|
|
2021
Q2 | $332K | Buy |
2,145
+194
| +10% | +$30K | ﹤0.01% | 1828 |
|
|
2021
Q1 | $308K | Buy |
1,951
+158
| +9% | +$24.9K | ﹤0.01% | 1789 |
|
|
2020
Q4 | $416K | Buy |
1,793
+431
| +32% | +$100K | ﹤0.01% | 1383 |
|
|
2020
Q3 | $298K | Sell |
1,362
-53
| -4% | -$11.6K | ﹤0.01% | 1182 |
|
|
2020
Q2 | $402K | Buy |
1,415
+607
| +75% | +$172K | ﹤0.01% | 1062 |
|
|
2020
Q1 | $233K | Sell |
808
-636
| -44% | -$183K | ﹤0.01% | 958 |
|
|
2019
Q4 | $415K | Sell |
1,444
-120
| -8% | -$34.5K | ﹤0.01% | 1162 |
|
|
2019
Q3 | $226K | Buy |
1,564
+33
| +2% | +$4.77K | ﹤0.01% | 1381 |
|
|
2019
Q2 | $138K | Sell |
1,531
-203
| -12% | -$18.3K | ﹤0.01% | 1501 |
|
|
2019
Q1 | $152K | Buy |
1,734
+22
| +1% | +$1.93K | ﹤0.01% | 1522 |
|
|
2018
Q4 | $241K | Sell |
1,712
-330
| -16% | -$46.5K | ﹤0.01% | 1270 |
|
|
2018
Q3 | $522K | Sell |
2,042
-75
| -4% | -$19.2K | ﹤0.01% | 1083 |
|
|
2018
Q2 | $540K | Buy |
2,117
+288
| +16% | +$73.5K | ﹤0.01% | 1076 |
|
|
2018
Q1 | $368K | Sell |
1,829
-200
| -10% | -$40.2K | ﹤0.01% | 1233 |
|
|
2017
Q4 | $292K | Buy |
2,029
+104
| +5% | +$15K | ﹤0.01% | 1404 |
|
|
2017
Q3 | $317K | Buy |
1,925
+115
| +6% | +$18.9K | ﹤0.01% | 1119 |
|
|
2017
Q2 | $246K | Buy |
1,810
+134
| +8% | +$18.2K | ﹤0.01% | 1262 |
|
|
2017
Q1 | $323K | Sell |
1,676
-431
| -20% | -$83.1K | ﹤0.01% | 1207 |
|
|
2016
Q4 | $297K | Buy |
2,107
+438
| +26% | +$61.7K | ﹤0.01% | 1373 |
|
|
2016
Q3 | $244K | Sell |
1,669
-308
| -16% | -$45K | ﹤0.01% | 1240 |
|
|
2016
Q2 | $199K | Buy |
1,977
+25
| +1% | +$2.52K | ﹤0.01% | 1429 |
|
|
2016
Q1 | $261K | Sell |
1,952
-188
| -9% | -$25.1K | ﹤0.01% | 1273 |
|
|
2015
Q4 | $425K | Buy |
2,140
+177
| +9% | +$35.2K | 0.01% | 1115 |
|
|
2015
Q3 | $310K | Sell |
1,963
-133
| -6% | -$21K | ﹤0.01% | 1132 |
|
|
2015
Q2 | $855K | Sell |
2,096
-9
| -0.4% | -$3.67K | 0.01% | 849 |
|
|
2015
Q1 | $967K | Buy |
2,105
+467
| +29% | +$215K | 0.01% | 860 |
|
|
2014
Q4 | $920K | Buy |
+1,638
| New | +$920K | 0.01% | 898 |
|
|
2014
Q3 | – | Sell |
-402
| Closed | -$281K | – | 2331 |
|
|
2014
Q2 | $281K | Sell |
402
-126
| -24% | -$88.1K | ﹤0.01% | 1952 |
|
|
2014
Q1 | $244K | Buy |
+528
| New | +$244K | ﹤0.01% | 2382 |
|